Injecting Hope: Clinical Development of the NeuVax Vaccine

Elizabeth Mittendorf

Associate Professor, Deputy Chair Research, Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center

ABSTRACT

This presentation will focus of the clinical trials evaluating NeuVax, a peptide vaccine comprised of the immunogenic epitope E75 and the immunoadjuvant GM-CSF. An update on the ongoing phase III registration trial will be presented.

BIO